TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.
Market News Page 5 of 232 • 5,789 articles
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc. • Rosen Law Firm
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/23/2025 11:45 PM • The Rosen Law Firm is investigating potential securities claims against Alvotech (NASDAQ: ALVO) following allegations of materially misleading business information. The investigation was triggered by Alvotech's November 2, 2025 announcement that the FDA issued a complete response letter for its AVT05 biologics license application, citing manufacturing deficiencies. The stock fell 34% on November 3, 2025, following the news. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

NEM - Gold mining company with low P/E ratio, experiencing price volatility but maintaining strong potential with price target above current trading level
ALVO - The company issued materially misleading information regarding its FDA application status. The FDA's complete response letter citing manufacturing deficiencies resulted in a 34% stock price decline, triggering a securities class action investigation for investor losses.
#securities fraud #class action lawsuit #FDA rejection #biologics license application #manufacturing deficiencies #investor losses #stock decline
Read More
Synopsys, Inc. Notice of December 30, 2025 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
Synopsys, Inc. Notice of December 30, 2025 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

12/23/2025 10:37 PM • Kahn Swick & Foti, LLC announces a class action securities lawsuit against Synopsys, Inc. for alleged securities fraud between December 4, 2024 and September 9, 2025. The lawsuit was triggered after Synopsys missed Q3 2025 revenue guidance ($1.740B vs. $1.755-1.785B guidance) and reported a 43% year-over-year decline in net income. The Design IP segment declined 7.7% year-over-year with guidance suggesting at least 5% full-year decline. Stock price fell 35.8% on the announcement. Investors have until December 30, 2025 to request lead plaintiff status.

JPMpL - Set a fresh record, stock price increased 1.90%
SNPS - Company missed quarterly revenue guidance, reported significant year-over-year net income decline of 43%, Design IP segment declined 7.7% with negative full-year outlook, and stock price fell 35.8% on the announcement. These factors triggered a securities fraud class action lawsuit.
#class action lawsuit #securities fraud #missed revenue guidance #earnings decline #stock price drop #Design IP segment #lead plaintiff deadline
Read More
Jayud Global Logistics Ltd. Notice of January 19, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
Jayud Global Logistics Ltd. Notice of January 19, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

12/23/2025 10:35 PM • Kahn Swick & Foti, LLC announces a class action securities lawsuit against Jayud Global Logistics Limited for alleged securities fraud between April 21, 2023 and April 30, 2025. The lawsuit claims the company was subject to a fraudulent 'pump-and-dump' scheme involving social media misinformation, impersonated financial professionals, and coordinated share dumping by insiders using offshore accounts. Investors who suffered losses have until January 19, 2026 to request lead plaintiff status.

JPMpM - Set a fresh record, stock price increased 1.90%
JYD - The company is the subject of a class action lawsuit alleging securities fraud, fraudulent stock promotion schemes, market manipulation through coordinated share dumping, and materially misleading public statements about business operations and prospects.
#class action lawsuit #securities fraud #pump-and-dump scheme #stock manipulation #investor losses #misleading statements #offshore accounts
Read More
DeFi Technologies Inc. Notice of January 30, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
DeFi Technologies Inc. Notice of January 30, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

12/23/2025 10:34 PM • A class action securities lawsuit has been filed against DeFi Technologies Inc. (DEFT) for alleged fraud between May 12 and November 14, 2025. The company disclosed a 20% revenue decline and slashed its 2025 revenue forecast from $218.6 million to $116.6 million, citing delays in executing arbitrage opportunities. The stock fell 27.59% following the announcement. Investors have until January 30, 2026 to apply as lead plaintiffs.

VYLD - Set a fresh record, stock price increased 1.90%
DEFT - The company faces a class action lawsuit for alleged securities fraud, disclosed a nearly 20% revenue decline significantly below expectations, slashed full-year revenue guidance by 46% (from $218.6M to $116.6M), and experienced a 27.59% stock price decline following the announcement. These factors indicate serious operational and financial challenges.
#class action lawsuit #securities fraud #revenue decline #stock price drop #DeFi Technologies #financial misstatement
Read More
F5, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
F5, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

12/23/2025 10:33 PM • F5, Inc. faces a securities class action lawsuit for failing to disclose material information about a security breach in its BIG-IP product during the Class Period (October 28, 2024 - October 27, 2025). The company announced significantly below-market growth expectations for fiscal 2026, resulting in a 10.9% stock price decline from $290.41 to $258.76 per share on October 27-28, 2025. Investors have until February 17, 2026 to file lead plaintiff applications.

CRCL - Slumped more than 10% despite beating earnings expectations due to higher-than-expected operating costs
FFIV - F5 faces securities fraud allegations for failing to disclose a material security breach affecting its highest revenue product (BIG-IP). The company disclosed significantly below-market growth expectations, reduced sales projections, and increased expenses. The stock declined 10.9% following the announcement, and investors are pursuing legal action for economic losses.
#securities fraud #class action lawsuit #data breach #BIG-IP #stock decline #material information disclosure #lead plaintiff
Read More
Coupang, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
Coupang, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

12/23/2025 10:32 PM • Coupang, Inc. faces a securities class action lawsuit for allegedly failing to disclose a material data breach where a former employee accessed sensitive customer information for nearly six months without detection. Investors who purchased securities between August 6, 2025 and December 16, 2025 can file lead plaintiff applications by February 17, 2026. The lawsuit alleges the company violated federal securities laws by not properly reporting the breach and making false public statements.

CPNG - The company is facing securities fraud allegations for inadequate cybersecurity protocols, failure to disclose a material data breach, and non-compliance with SEC reporting requirements. These violations resulted in stock decline and investor losses during the class period.
#data breach #securities fraud #class action lawsuit #cybersecurity #material disclosure #SEC reporting #investor losses
Read More
Bitdeer Technologies Group Securities Fraud Class Action Result of Undisclosed Financial Problems and 14% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire Inc. • Kahn Swick & Foti, Llc
Bitdeer Technologies Group Securities Fraud Class Action Result of Undisclosed Financial Problems and 14% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

12/23/2025 10:31 PM • Bitdeer Technologies Group faces a securities class action lawsuit for failing to disclose material financial information during the period from June 6, 2024 to November 10, 2025. The company announced a widened net loss of $266.7 million in Q3 2025 due to increased R&D expenses, causing its stock to plummet 14% from $17.65 to $15.02 per share. Investors have until February 2, 2026 to file lead plaintiff applications.

BULLW - The company is proactively adopting innovative AI technology to enhance user experience, differentiate from competitors, and provide more targeted investment information
BTDR - The company is facing securities fraud allegations for failing to disclose material financial information. It reported a significantly widened net loss of $266.7 million in Q3 2025, and its stock declined 14% following the announcement. These factors indicate serious financial and legal troubles.
#securities fraud #class action lawsuit #undisclosed financial problems #stock decline #net loss #ASIC roadmap #Bitcoin mining
Read More
Hainan FTP's customs closure begins: departure of duty-free processed and value-added goods from island
GlobeNewswire Inc. • The Publicity Department Of The Sanya Municipal Party Committee
Hainan FTP's customs closure begins: departure of duty-free processed and value-added goods from island

12/23/2025 09:53 PM • Hainan Heren Pearl Co., Ltd. shipped the first batch of duty-free processed jewelry from Sanya following the customs closure at Hainan Free Trade Port. The company reduced its comprehensive tax rate from 51.92% to 25.56%, lowering production costs. Sanya has attracted major jewelry companies and established industrial parks, with 9,838 new declaration units registered this year and 650 million yuan in zero-tariff imports generating 150 million yuan in tax savings.

JPMpD - Set a fresh record, stock price increased 1.90%
ZHAOY - Established presence in Sanya's jewelry industrial parks, benefiting from FTP policies and the developing full-chain industrial ecosystem.
#Hainan Free Trade Port #duty-free processing #jewelry industry #tax reduction #industrial cluster #value-added goods #Sanya customs
Read More
TLX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
GlobeNewswire Inc. • Rosen Law Firm
TLX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

12/23/2025 09:44 PM • Rosen Law Firm reminds investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) who purchased securities between February 21, 2025 and August 28, 2025 of the January 9, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Telix made materially false and misleading statements regarding progress on prostate cancer therapeutics, supply chain quality, and business prospects.

JPMpJ - Set a fresh record, stock price increased 1.90%
TLX - The company is the subject of a securities class action lawsuit alleging material misstatements and omissions regarding prostate cancer therapeutic progress, supply chain quality, and business operations. Investors who purchased during the class period may have suffered damages.
#securities class action #lead plaintiff deadline #Telix Pharmaceuticals #false statements #prostate cancer therapeutics #supply chain #investor compensation
Read More
NUAI Announcement: If You Have Suffered Losses in New Era Energy & Digital, Inc. (NASDAQ: NUAI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc. • The Rosen Law Firm
NUAI Announcement: If You Have Suffered Losses in New Era Energy & Digital, Inc. (NASDAQ: NUAI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/23/2025 09:38 PM • The Rosen Law Firm announced an investigation into potential securities claims against New Era Energy & Digital, Inc. (NASDAQ: NUAI) following a short seller report by Fuzzy Panda Research alleging the company spent 2.5 times more on stock promotions than operating expenses and that CEO E. Will Gray II has a history of running penny stock companies into the ground. The stock fell 6.9% on December 12, 2025, following the report's release.

JPMpK - Set a fresh record, stock price increased 1.90%
NUAI - The company faces allegations of issuing materially misleading information, excessive spending on stock promotions relative to operations, and CEO's history of mismanagement. Stock declined 6.9% following the short seller report, and a securities class action investigation has been initiated.
#securities fraud #class action lawsuit #short seller report #stock promotion #penny stock #investor losses #misleading business information
Read More
Is Amazon Stock Still a Buy After Hitting All-Time Highs?
The Motley Fool • Manali Pradhan, Cfa
Is Amazon Stock Still a Buy After Hitting All-Time Highs?

12/23/2025 08:37 PM • Amazon stock has reached all-time highs but analysts believe it can continue climbing. AWS cloud services are experiencing strong growth with a $200 billion backlog driven by AI infrastructure demand, while the advertising business is becoming increasingly profitable. The company plans significant capital investments in AI infrastructure, positioning it for accelerated growth despite current valuation levels.

JPMpC - Set a fresh record, stock price increased 1.90%
AMZN - AWS shows robust 20.2% YoY revenue growth with $200B backlog providing multiyear visibility; advertising revenue grew 22% YoY and is becoming highly profitable; company planning major AI infrastructure investments; analyst expects stock can surpass all-time highs despite current elevated valuations
#Amazon #AWS #cloud computing #artificial intelligence #advertising revenue #capital investment #stock valuation
Read More
Dr. Andrea Adams-Miller Warns Boards Face Rising Governance Risk as AI Outpaces Human Judgment
GlobeNewswire Inc. • Dr. Andrea Adams-Miller
Dr. Andrea Adams-Miller Warns Boards Face Rising Governance Risk as AI Outpaces Human Judgment

12/23/2025 07:51 PM • Dr. Andrea Adams-Miller warns that rapid AI expansion in companies has created a governance gap that boards have not adequately addressed. As AI systems guide critical business decisions faster than leaders can evaluate them, boards face increased risk. Recent cases at Amazon and Zillow highlight governance failures when oversight lags behind technology. Adams-Miller recommends boards implement clear human ownership, plain-language explanations, defined pause points, and communication readiness for AI-driven decisions.

GSpD - Set a fresh record, stock price increased 2.73%
AMZN - Company cited as a cautionary example of governance failure; leadership had to shut down an internal AI hiring tool after it demonstrated bias against female candidates, indicating inadequate review and testing processes.
#AI governance #corporate boards #risk management #decision-making #AI oversight #leadership accountability #regulatory concerns
Read More
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
GlobeNewswire Inc. • Agios Pharmaceuticals, Inc.
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

12/23/2025 07:45 PM • The FDA has approved Agios Pharmaceuticals' AQVESME (mitapivat), an oral pyruvate kinase activator, for treating anemia in adults with alpha- or beta-thalassemia. AQVESME is the only FDA-approved medicine for both non-transfusion-dependent and transfusion-dependent forms of the disease. The approval is based on Phase 3 ENERGIZE and ENERGIZE-T trials showing significant improvements in hemoglobin levels, fatigue, and transfusion burden. The drug will be available in late January 2026 under a REMS program due to hepatocellular injury risks observed in clinical trials.

AMJB - Set a fresh record, stock price increased 1.90%
AGIO - FDA approval of AQVESME represents a significant milestone for the company, establishing it as the only approved treatment for both transfusion-dependent and non-transfusion-dependent thalassemia. The approval is based on successful Phase 3 trials meeting primary and secondary endpoints. However, the positive sentiment is tempered by the requirement for a restrictive REMS program due to hepatocellular injury risks observed in 5 patients during trials, which may impact market adoption and commercial success.
#FDA approval #mitapivat #thalassemia #anemia treatment #pyruvate kinase activator #ENERGIZE trials #REMS program #hepatocellular injury #rare disease
Read More
NJDCY Announcement: If You Have Suffered Losses in Nidec Corporation (OTC: NJDCY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc. • The Rosen Law Firm
NJDCY Announcement: If You Have Suffered Losses in Nidec Corporation (OTC: NJDCY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/23/2025 07:32 PM • The Rosen Law Firm is investigating potential securities claims against Nidec Corporation after the company announced a probe into accounting issues at its China unit. Nidec's ADRs fell 22.7% on September 4, 2025, following the disclosure. The firm is preparing a class action lawsuit to recover investor losses.

JPM - Set a fresh record, stock price increased 1.90%
NJDCY - The company disclosed accounting issues in its China unit, leading to a 22.7% stock price decline and triggering a securities class action investigation. This represents material negative information that harmed shareholder value.
#securities fraud #accounting issues #class action lawsuit #investor losses #China unit probe #stock decline
Read More
Osisko Development and Electric Elements File Early Warning Report for Niobay Metals Inc.
GlobeNewswire Inc. • Na
Osisko Development and Electric Elements File Early Warning Report for Niobay Metals Inc.

12/23/2025 06:57 PM • Osisko Development Corp. acquired 8,571,429 units of Niobay Metals Inc. for $1.2 million on December 18, 2025, increasing its ownership stake from 10.8% to 12.3% on a basic basis. The investment was made through its subsidiary Barkerville Gold Mines Ltd. as part of Niobay's private placement offering.

GSpC - Set a fresh record, stock price increased 2.73%
ODV - Company is actively expanding its investment portfolio by acquiring a significant stake in Niobay Metals, demonstrating confidence in growth opportunities and strategic diversification beyond its flagship Cariboo Gold Project.
#private placement #equity investment #Niobay Metals #ownership stake #warrant acquisition #gold development #Cariboo Gold Project
Read More
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
GlobeNewswire Inc. • Na
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn

12/23/2025 05:57 PM • Pelthos Therapeutics Inc. (NYSE American: PTHS) announced the appointment of veteran finance executive Andrew J. Einhorn to its Board of Directors effective immediately. Einhorn brings over four decades of experience in investment banking, capital markets, and C-level finance roles at life science companies. He will serve on the Audit Committee and Compensation Committee. The appointment increases the Pelthos Board to eight directors.

LLY - On pace for tenth gain in eleven sessions, stock price increased 1.89%
PTHS - The appointment of an experienced finance executive with 40+ years in investment banking and capital markets, combined with 20 years of CFO experience at biotech companies, signals strengthened financial leadership and governance. This is expected to support the company's growth as a newly public, commercially-focused biopharmaceutical company with an FDA-approved product (ZELSUVMI).
#board appointment #finance executive #biopharmaceutical #ZELSUVMI #molluscum contagiosum #FDA approval #capital markets #life science
Read More
Aduro Clean Technologies schließt öffentliches Emissionsangebot über 20 Millionen US-Dollar ab
GlobeNewswire Inc. • Na
Aduro Clean Technologies schließt öffentliches Emissionsangebot über 20 Millionen US-Dollar ab

12/23/2025 05:48 PM • Aduro Clean Technologies successfully closed a US$20 million underwritten public offering of common shares and warrants. The company plans to use the net proceeds for construction of its demonstration-scale plant, research and development, and working capital. D. Boral Capital LLC served as lead underwriter for the offering.

GSpA - Set a fresh record, stock price increased 2.73%
ADUR - The company successfully completed a US$20 million capital raise, demonstrating investor confidence in its clean technology platform. The funding will accelerate development of its demonstration-scale plant and R&D efforts, which are positive indicators for business expansion and commercialization of its Hydrochemolytic™ technology.
#public offering #clean technology #chemical recycling #plastic waste #capital raise #demonstration plant
Read More
À la clôture de son offre publique, Aduro Clean Technologies annonce la levée de 20 millions de dollars
GlobeNewswire Inc. • Na
À la clôture de son offre publique, Aduro Clean Technologies annonce la levée de 20 millions de dollars

12/23/2025 05:48 PM • Aduro Clean Technologies successfully closed a US$20 million underwritten public offering, issuing 1,739,130 common shares with warrants. The company plans to use the net proceeds to finance construction of its demonstration-scale plant, with remaining funds allocated to R&D, general operations, and working capital. D. Boral Capital LLC served as the lead underwriter.

GS - Set a fresh record, stock price increased 2.73%
ADUR - The company successfully closed a significant US$20 million capital raise, demonstrating investor confidence and providing substantial funding to advance its demonstration-scale plant construction and R&D initiatives. This is a concrete achievement that supports the company's growth trajectory in the clean technology sector.
#public offering #capital raise #clean technology #plastic recycling #demonstration plant #warrants #underwriting
Read More
Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change
GlobeNewswire Inc. • Can-Fite Biopharma Ltd.
Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change

12/23/2025 04:46 PM • Can-Fite BioPharma announced a 1-for-3,000 reverse stock split of its ordinary shares, approved by shareholders on November 10, 2025, effective January 5, 2026 on the Tel-Aviv Stock Exchange and NYSE American. The reverse split will also adjust the ADS ratio from 1 ADS representing 300 ordinary shares to 1 ADS representing 2 ordinary shares, equivalent to a 1-for-20 ADS split. The company's authorized shares will be reduced from 42 billion to 14 million.

PNC - Acquiring a well-performing regional bank with strong community presence and committed to retaining local leadership and branch network
CANF - Reverse stock splits of this magnitude (1-for-3,000) are typically executed by companies facing severe stock price depreciation and are often viewed negatively by investors as a sign of financial distress or failed business performance. While the split itself is neutral mechanically, the need for such an extreme consolidation indicates underlying business challenges.
#reverse stock split #ADS ratio change #shareholder approval #stock consolidation #NYSE American #Tel-Aviv Stock Exchange
Read More
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
GlobeNewswire Inc. • Compass Minerals International, Inc.
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

12/23/2025 04:43 PM • Compass Minerals has agreed to settle derivative lawsuits alleging that company directors and officers breached fiduciary duties by issuing false statements about magnesium chloride-based fire retardants and overstating U.S. Forest Service contract prospects. The settlement requires adoption of corporate governance reforms and includes $850,000 in attorneys' fees to be paid by company insurers. A settlement hearing is scheduled for February 20, 2026.

CMP - While the settlement avoids prolonged litigation costs and risks, it acknowledges serious allegations of misleading statements about product safety and contract prospects. The required governance reforms suggest past governance deficiencies. However, the settlement is presented as beneficial to the company and stockholders by avoiding further litigation distraction and implementing improvements. The neutral sentiment reflects both the resolution of legal risk and the underlying governance concerns that prompted the lawsuit.
#derivative litigation #settlement #corporate governance reforms #fiduciary duty #magnesium chloride fire retardants #U.S. Forest Service contract #stockholder rights
Read More
Amplify Energy Announces Closing of East Texas Divestiture
GlobeNewswire Inc. • Na
Amplify Energy Announces Closing of East Texas Divestiture

12/23/2025 04:35 PM • Amplify Energy Corp. announced the closure of its East Texas asset sale for $122.0 million on December 23, 2025. The company is divesting assets as part of strategic initiatives, with an Oklahoma asset sale still expected to close by year-end 2025. Amplify operates in Oklahoma, Pacific Offshore, and the Rockies regions.

AMPY - The company successfully closed a major asset sale at the announced price of $122 million, demonstrating execution on strategic plans. However, the ongoing divestiture of core assets and need for strategic alternatives suggest underlying operational or financial challenges. The sale itself is neither inherently positive nor negative without context on valuation relative to asset quality or company needs.
#asset divestiture #East Texas sale #Oklahoma assets #oil company #strategic initiatives #capital allocation
Read More
ICZOOM Group Inc. Announces Extraordinary General Meeting of Shareholders
GlobeNewswire Inc. • Iczoom Group Inc.
ICZOOM Group Inc. Announces Extraordinary General Meeting of Shareholders

12/23/2025 04:00 PM • ICZOOM Group Inc. (Nasdaq: IZM), a B2B electronic component e-commerce platform, announced an extraordinary general meeting scheduled for February 27, 2026, in response to a shareholder requisition dated December 5, 2025. The meeting will allow shareholders to vote on proposed changes to the company's board and management. Shareholders of record as of February 2, 2026, will be eligible to vote.

IZM - The announcement of an extraordinary general meeting triggered by a shareholder requisition requesting changes to the board and management indicates internal corporate governance issues and shareholder dissatisfaction. This typically signals organizational instability and potential conflicts between management and shareholders, which is generally viewed negatively by the market.
#extraordinary general meeting #shareholder requisition #board changes #management changes #B2B e-commerce #electronic components
Read More
Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share
GlobeNewswire Inc. • Na
Riverview Bancorp Declares Quarterly Cash Dividend of $0.02 Per Share

12/23/2025 04:00 PM • Riverview Bancorp, Inc. announced on December 23, 2025, that its Board of Directors approved a quarterly cash dividend of $0.02 per share, unchanged from the previous quarter. The dividend is payable on January 16, 2026, to shareholders of record as of January 5, 2026. Riverview, headquartered in Vancouver, Washington, operates as a community bank with $1.51 billion in assets and 17 branches across the Portland-Vancouver area.

VSTM - First FDA approval for KRAS-mutated recurrent Low-grade Serous Ovarian Cancer treatment
RVSB - The company maintained its dividend at $0.02 per share with no change from the preceding quarter, indicating stable but not growing shareholder returns. While dividend maintenance is positive, the lack of increase and the modest dividend amount suggest a cautious or conservative approach rather than strong growth momentum.
#quarterly dividend #cash dividend #community banking #shareholder returns #Riverview Bank
Read More
Halper Sadeh LLC Encourages CWAN and JHG Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc. • Halper Sadeh Llc
Halper Sadeh LLC Encourages CWAN and JHG Shareholders to Contact the Firm to Discuss Their Rights

12/23/2025 03:52 PM • Halper Sadeh LLC, an investor rights law firm, is investigating Clearwater Analytics Holdings (CWAN) and Janus Henderson Group (JHG) for potential securities law violations and breaches of fiduciary duties related to their respective acquisitions. CWAN is being acquired by Permira and Warburg Pincus for $24.55 per share, while JHG is being acquired by Trian Fund Management and General Catalyst for $49.00 per share. The firm is seeking increased consideration for shareholders and additional disclosures.

CWAN - Company is under investigation for potential securities law violations and breaches of fiduciary duties in connection with its acquisition, suggesting shareholders may not have received fair consideration or adequate disclosures.
#acquisition #securities investigation #fiduciary duty #shareholder rights #merger
Read More
Sampo Oyj:n omien osakkeiden ostot 23.12.2025
GlobeNewswire Inc. • Sampo Oyj
Sampo Oyj:n omien osakkeiden ostot 23.12.2025

12/23/2025 03:00 PM • Sampo Oyj announced the acquisition of 254,351 of its own A-shares on December 23, 2025, at a weighted average price of €10.30 per share across multiple trading venues. Following these transactions, Sampo now holds 8,432,498 treasury shares, representing 0.32% of all shares outstanding. The buyback is part of the €150 million share repurchase program authorized by the Annual General Meeting on April 23, 2025, and initiated on November 6, 2025.

SAXPY - The share buyback is a routine capital allocation activity executed as part of a pre-announced program. While buybacks can be viewed positively as returning value to shareholders, this is a standard operational announcement with no indication of exceptional circumstances or strategic changes. The execution at €10.30 per share appears orderly and systematic.
#share buyback #treasury shares #A-shares #share repurchase program #weighted average price #capital allocation
Read More